Tingley Whittemore's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Mar 10, 2025
- Accession no.
- 0000950170-25-036772
- Filed
- Mar 10, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.99K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tingley WhittemoreCIK 0001868494 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | SSaleDisposed | −1,727 | $0.54 | −$932.58 | 180,464 | Direct | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −4,073 | $0.54 | −$2,199.42 | 176,391 | Direct | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −1,598 | $0.54 | −$862.92 | 174,793 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.